Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOZOL: Zometa in Neoadjuvant Breast Cancer Treatment
NCT01367288Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Apr 2010
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in breast cancer, sponsored by Hospices Civils de Lyon. Started Apr 2010; status: completed.
02
Drugs
zoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01367288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01367288.